Dr. Zhang is the originator and CEO of Insignis Therapeutics Inc., a distinct pharmaceutical organization committed to formulating and bringing to market a convenient oral epinephrine tablet for the emergency management of anaphylaxis, a severe allergic reaction. Additionally, Dr. Zhang holds the position of president at 3RServices LLC, a company he established in 2013 to aid pharmaceutical and biotech firms in translating novel scientific findings into significant medical treatments. Throughout his career in the pharmaceutical industry, Dr. Zhang has played pivotal roles in advancing several drug candidates into clinical trials.
Insignis Therapeutics
Headquarters
United States of America